Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,54117,560 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
NATIONAL CANCER INSTITUTE Rockefeller University United States 2021 – 2026

ABSTRACT Although the past decade was marked by the tremendous success of immunotherapeutics in oncology, few have provided significant benefit to patients with pancreatic cancer....

$5.32M
USD
Completed NON-SBIR/STTR RPGS
rPIV5- and AVLP-vectored vaccine development with public tumor-specific neoantigens
NATIONAL CANCER INSTITUTE University of Georgia United States 2021 – 2026

Abstract This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA- 23-045. The proposed supplement project aims to validate the...

$1.47M
USD
Completed NON-SBIR/STTR RPGS
Canine MHC-I genotyping and tumor specific neoantigen determination
NATIONAL CANCER INSTITUTE University of Georgia United States 2021 – 2026

Abstract Being naturally occurring and with an intact immune system, spontaneous cancers in pet dogs have the potential to effectively bridge a current gap between preclinical mode...

$4.37M
USD
Completed NON-SBIR/STTR RPGS
Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
NATIONAL CANCER INSTITUTE Rockefeller University United States 2021 – 2026

ABSTRACT Although the past decade was marked by the tremendous success of immunotherapeutics in oncology, few have provided significant benefit to patients with pancreatic cancer....

$5.15M
USD
Completed NON-SBIR/STTR RPGS
TNBC Ligand-displaying Exosomes Using RNA Nanotechnology for Targeted Cytosol Delivery of RNAi without Endosome Entrapment
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2026

SUMMARY Triple negative breast cancer (TNBC) is a heterogeneous, complex, and aggressive breast cancer subtype. TNBC patients respond poorly to chemotherapy, leading to high mortal...

$3.55M
USD
Completed NON-SBIR/STTR RPGS
(PQ4) Role of HIV-induced PLK1 Activation in Regulation of gamma-Herpesvirus Reservoirs in Lymphocytes
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2026

PROJECT SUMMARY Gammaherpesvirus infections are associated with a number of malignancies that include B-cell lymphoproliferative diseases, gastric carcinoma, nasopharyngeal carcino...

$3.88M
USD
Completed NON-SBIR/STTR RPGS
AI Transfer of the MHC-I Immunopeptidome from Human to Dog
NATIONAL CANCER INSTITUTE University of Georgia United States 2021 – 2026

Abstract This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA- 24-029. It is submitted as a supplement to our parent R01CA2...

$1.59M
USD
Active NON-SBIR/STTR RPGS
Investigating the mechanisms of driver genes associated with ancestry and aggressiveness in prostate cancer
NATIONAL CANCER INSTITUTE Boston University Medical Campus United States 2021 – 2027

Summary African American (AA) men have the highest incidence and mortality rate from prostate cancer in the United States. We recently showed that AA men with low-risk prostate can...

$1.97M
USD
Active NON-SBIR/STTR RPGS
Survivorship and Access to care for Latinos to Understand and address Disparities (SALUD)
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2027

ABSTRACT Pediatric cancer survivors (PCS) experience an excess risk of adverse outcomes related to their cancer diagnosis and the treatment they receive. The accumulation and sever...

$21.83M
USD
Completed OTHERS
Cancer Grand Challenges: Operations Management Application
NATIONAL CANCER INSTITUTE Cancer Research United Kingdom United Kingdom 2021 – 2024

Cancer Research UK (CRUK) established its ‘Grand Challenge’ initiative in 2015 to support international, interdisciplinary teams of elite scientists and clinicians to address some...

$11.14M
USD
Active NON-SBIR/STTR RPGS
Investigating the mechanisms of driver genes associated with ancestry and aggressiveness in prostate cancer
NATIONAL CANCER INSTITUTE Boston University Medical Campus United States 2021 – 2027

Summary African American (AA) men have the highest incidence and mortality rate from prostate cancer in the United States. We recently showed that AA men with low-risk prostate can...

$6.55M
USD
Active NON-SBIR/STTR RPGS
Survivorship and Access to care for Latinos to Understand and address Disparities (SALUD)
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2027

ABSTRACT Pediatric cancer survivors (PCS) experience an excess risk of adverse outcomes related to their cancer diagnosis and the treatment they receive. The accumulation and sever...

$17.67M
USD
Completed OTHERS
Cancer Grand Challenges: Operations Management Application
NATIONAL CANCER INSTITUTE Cancer Research United Kingdom United Kingdom 2021 – 2025

Cancer Research UK (CRUK) established its ‘Grand Challenge’ initiative in 2015 to support international, interdisciplinary teams of elite scientists and clinicians to address some...

$8.2M
USD
Completed NON-SBIR/STTR RPGS
Survivorship and Access to care for Latinos to Understand and address Disparities (SALUD)
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2023

ABSTRACT Pediatric cancer survivors (PCS) experience an excess risk of adverse outcomes related to their cancer diagnosis and the treatment they receive.The accumulation and severi...

$10.57M
USD
Completed NON-SBIR/STTR RPGS
Investigating the mechanisms of driver genes associated with ancestry and aggressiveness in prostate cancer
NATIONAL CANCER INSTITUTE Boston University Medical Campus United States 2021 – 2026

Summary African American (AA) men have the highest incidence and mortality rate from prostate cancer in the United States. We recently showed that AA men with low-risk prostate can...

$5.86M
USD
Completed NON-SBIR/STTR RPGS
Interaction of HTLV-1 Tax & Hbz in Transformation
NATIONAL CANCER INSTITUTE Washington University United States 2021 – 2024

Interaction of HTLV-1 Tax & Hbz in Transformation Abstract Human T-cell leukemia virus type 1 (HTLV-1) is the cause of a refractory T cell lymphoproliferative disorder, designa...

$2.16M
USD
Completed NON-SBIR/STTR RPGS
Survivorship and Access to care for Latinos to Understand and address Disparities (SALUD)
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2023

ABSTRACT Pediatric cancer survivors (PCS) experience an excess risk of adverse outcomes related to their cancer diagnosis and the treatment they receive. The accumulation and sever...

$9.69M
USD
Completed NON-SBIR/STTR RPGS
RNASEH2B loss to predict response to PARP inhibitor in prostate cancer
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2023

ABSTRACT Metastatic castration-resistant prostate cancer (CRPC) is an incurable disease that is expected to account for ~ 31,000 deaths each year in the United States. There are li...

$2.05M
USD
Completed OTHERS
Cancer Grand Challenges: Operations Management Application
NATIONAL CANCER INSTITUTE Cancer Research United Kingdom United Kingdom 2021 – 2023

No Text

$8.32M
USD
Completed NON-SBIR/STTR RPGS
Interaction of HTLV-1 Tax & Hbz in Transformation
NATIONAL CANCER INSTITUTE Washington University United States 2021 – 2023

Interaction of HTLV-1 Tax & Hbz in Transformation Abstract Human T-cell leukemia virus type 1 (HTLV-1) is the cause of a refractory T cell lymphoproliferative disorder, designa...

$1.84M
USD